Invention Grant
US09212227B2 ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
有权
ST2L抗体拮抗剂用于治疗ST2L介导的炎症性肺病
- Patent Title: ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
- Patent Title (中): ST2L抗体拮抗剂用于治疗ST2L介导的炎症性肺病
-
Application No.: US13798226Application Date: 2013-03-13
-
Publication No.: US09212227B2Publication Date: 2015-12-15
- Inventor: Karen Duffy , Natalie Fursov , LeRoy Hall , Catherine Healy , Roberta Lamb , Jinquan Luo , Ravi Malaviya , Michael Naso , Michael Pratta , Mark Tornetta , John Wheeler , Sheng-Jiun Wu
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Kirk Baumeister
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K38/01 ; C07K16/44 ; C07K16/18 ; A61K39/00
Abstract:
The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.
Public/Granted literature
- US20130287777A1 ST2L Antagonists and Methods of Use Public/Granted day:2013-10-31
Information query
